How has Bicara Therapeutics's professional service fees payable changed year-over-year?

Bicara Therapeutics's professional service fees payable decreased by 68.4% year-over-year, from $5.27M to $1.67M.

What is the long-term trend for Bicara Therapeutics's professional service fees payable?

Over 2 years (2023 to 2025), Bicara Therapeutics's professional service fees payable has grown at a 79.2% compound annual growth rate (CAGR), from $184K to $591K.

Bicara Therapeutics BCAX Professional Service Fees Payable

Professional Service Fees Payable at other companies

Nuvation BioNUVB

$17.23M+6.1%

Inhibrx Biosciences, Inc.INBX

——

Viridian Therapeutics, Inc.VRDN

——

Immunovant, Inc.IMVT

——

Vir Biotechnology, Inc.VIR

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's professional service fees payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's professional service fees payable?: Bicara Therapeutics (BCAX) reported professional service fees payable of $1.67M in Q1 2026.
How has Bicara Therapeutics's professional service fees payable changed year-over-year?: Bicara Therapeutics's professional service fees payable decreased by 68.4% year-over-year, from $5.27M to $1.67M.
What is the long-term trend for Bicara Therapeutics's professional service fees payable?: Over 2 years (2023 to 2025), Bicara Therapeutics's professional service fees payable has grown at a 79.2% compound annual growth rate (CAGR), from $184K to $591K.